Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Results symbols : TEVJF save search
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
Published: 2024-04-11 (Crawled : 23:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -1.01%
H: 2.04%
C: 1.17%
ajovy for teva trial migraine china results
Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024
Published: 2024-04-09 (Crawled : 23:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -0.7%
H: 0.07%
C: -0.92%
first conference teva financial results
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: -1.58%
H: 1.87%
C: 0.53%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: -1.86%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.58%
H: 1.2%
C: 0.84%
business year update financial results
Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
Published: 2024-03-05 (Crawled : 21:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: -0.99%
H: 0.75%
C: -0.13%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: -6.12%
H: 1.67%
C: 1.17%
year financial results
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Published: 2024-01-29 (Crawled : 09:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: 2.39%
H: 4.67%
C: 1.67%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: -1.05%
H: 0.41%
C: -0.35%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.11%
H: 0.7%
C: 0.65%
avt03 prolia biosimilar positive results study
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT06 and Reference Product Eylea® (aflibercept)
Published: 2024-01-03 (Crawled : 09:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: 1.23%
H: 2.17%
C: 1.57%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: -0.97%
H: 1.53%
C: 0.0%
avt06 eylea candidate biosimilar results study
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
Published: 2024-01-02 (Crawled : 00:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: 0.29%
H: 3.53%
C: 1.91%
conference year teva financial results
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
Published: 2023-11-29 (Crawled : 09:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
avt05 simponi biosimilar positive results study
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.18%
H: 0.12%
C: -0.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Alvotech to Report Financial Results for the First Nine Months of 2023 on November 28, 2023, and Host Business Update Conference Call on November 29, 2023, at 8:00 am ET
Published: 2023-11-21 (Crawled : 13:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: -2.08%
H: 1.94%
C: 0.67%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: -0.21%
H: 1.06%
C: 0.85%
conference report business update financial results
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: 2.54%
H: 3.23%
C: -1.29%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
revenue teva financial results
Alvotech Reports Financial Results for First Six Months of 2023 and Provides Business Update
Published: 2023-08-30 (Crawled : 20:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: 0.21%
H: 3.28%
C: 1.54%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.35%
H: 0.12%
C: -1.03%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: 1.24%
H: 1.23%
C: 0.88%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.13%
H: 0.3%
C: -0.73%
six business update financial results
Alvotech to Report Financial Results for the First Half of 2023 on August 30, 2023, and Host Business Update Conference Call on August 31, 2023, at 8:00 am ET
Published: 2023-08-22 (Crawled : 13:20) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: -0.21%
H: 4.22%
C: 0.93%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: -1.43%
H: 0.0%
C: -0.73%
conference report business update financial results
Teva Reports Second Quarter 2023 Financial Results
Published: 2023-08-02 (Crawled : 15:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: 5.55%
H: 8.46%
C: 5.71%
teva financial results
Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August 2, 2023
Published: 2023-07-05 (Crawled : 23:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: 0.4%
H: 2.93%
C: -0.27%
conference teva financial results
Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update
Published: 2023-05-19 (Crawled : 09:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: 8.94%
H: 0.0%
C: -7.65%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.36%
H: 1.01%
C: 0.82%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.29%
H: 1.35%
C: 0.87%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.64%
H: 1.56%
C: 0.9%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: 2.31%
H: 1.86%
C: -0.2%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.09%
H: 0.64%
C: -0.45%
business update financial results
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
Published: 2023-05-10 (Crawled : 13:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -8.46%
H: 2.1%
C: 0.24%
teva financial results
Alvotech to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 18, 2023 and Host Conference Call on May 19, 2023 at 8:00 am ET
Published: 2023-05-03 (Crawled : 13:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: 2.54%
H: 0.45%
C: -2.97%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: 3.94%
H: 1.89%
C: -0.63%
conference report business financial results
Alvotech Announces Webcast of 2022 Full Year Financial Results at 8:00 am ET on March 2, 2023
Published: 2023-02-28 (Crawled : 01:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: -0.72%
H: 1.38%
C: 0.29%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: -0.47%
H: 2.86%
C: 2.86%
year financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.